ATE419853T1 - Thiazolopyrimidine zur verwendung in der therapie - Google Patents

Thiazolopyrimidine zur verwendung in der therapie

Info

Publication number
ATE419853T1
ATE419853T1 AT06744265T AT06744265T ATE419853T1 AT E419853 T1 ATE419853 T1 AT E419853T1 AT 06744265 T AT06744265 T AT 06744265T AT 06744265 T AT06744265 T AT 06744265T AT E419853 T1 ATE419853 T1 AT E419853T1
Authority
AT
Austria
Prior art keywords
therapy
thiazolopyrimidines
alkyl
group
nhalkyl
Prior art date
Application number
AT06744265T
Other languages
English (en)
Inventor
Fei-Yeu Zhao
Alistair Dixon
Johnathan Mark Treherne
Chizuko Koseki
Original Assignee
Sosei Group Corp
Neurosolutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei Group Corp, Neurosolutions Ltd filed Critical Sosei Group Corp
Application granted granted Critical
Publication of ATE419853T1 publication Critical patent/ATE419853T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06744265T 2005-06-20 2006-06-19 Thiazolopyrimidine zur verwendung in der therapie ATE419853T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0512554.7A GB0512554D0 (en) 2005-06-20 2005-06-20 Compounds for use in therapy

Publications (1)

Publication Number Publication Date
ATE419853T1 true ATE419853T1 (de) 2009-01-15

Family

ID=34855848

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06744265T ATE419853T1 (de) 2005-06-20 2006-06-19 Thiazolopyrimidine zur verwendung in der therapie

Country Status (19)

Country Link
US (1) US8349845B2 (de)
EP (1) EP1896031B1 (de)
JP (1) JP5055474B2 (de)
KR (1) KR20080076897A (de)
CN (1) CN101355947B (de)
AT (1) ATE419853T1 (de)
AU (1) AU2006260714B2 (de)
BR (1) BRPI0614386A2 (de)
CA (1) CA2612865C (de)
DE (1) DE602006004735D1 (de)
DK (1) DK1896031T3 (de)
ES (1) ES2323981T3 (de)
GB (1) GB0512554D0 (de)
IL (1) IL188061A0 (de)
NO (1) NO20080049L (de)
NZ (1) NZ564170A (de)
PT (1) PT1896031E (de)
WO (1) WO2006136806A1 (de)
ZA (1) ZA200711062B (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5564591A (en) * 1978-11-10 1980-05-15 Teijin Ltd Thiazolo 3, 2-a pyrimidine derivative, its preparation, and drug comprising it
JPS5566592A (en) * 1978-11-13 1980-05-20 Teijin Ltd 7-alkoxythiazolo 3,2-a pyrimidine derivative, its preparation, and drug containing the same
WO1981003174A1 (fr) * 1980-04-28 1981-11-12 Teijin Ltd Derives de thiazolo (3,2-a) pyrimidine, leur procede de preparation, et medicaments les contenant

Also Published As

Publication number Publication date
JP5055474B2 (ja) 2012-10-24
KR20080076897A (ko) 2008-08-20
JP2008543918A (ja) 2008-12-04
EP1896031B1 (de) 2009-01-07
IL188061A0 (en) 2011-08-01
GB0512554D0 (en) 2005-07-27
NZ564170A (en) 2011-03-31
HK1108842A1 (en) 2008-05-23
DK1896031T3 (da) 2009-05-11
DE602006004735D1 (de) 2009-02-26
CN101355947B (zh) 2013-06-05
NO20080049L (no) 2008-01-17
PT1896031E (pt) 2009-04-15
US20100216819A1 (en) 2010-08-26
ZA200711062B (en) 2010-06-30
AU2006260714B2 (en) 2008-11-13
CA2612865A1 (en) 2006-12-28
CA2612865C (en) 2013-03-26
WO2006136806A1 (en) 2006-12-28
US8349845B2 (en) 2013-01-08
ES2323981T3 (es) 2009-07-28
BRPI0614386A2 (pt) 2011-03-22
CN101355947A (zh) 2009-01-28
AU2006260714A1 (en) 2006-12-28
EP1896031A1 (de) 2008-03-12

Similar Documents

Publication Publication Date Title
SE0301882D0 (sv) New use I
SE0301886D0 (sv) New use V
SE0301888D0 (sv) New use VII
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
MX2020009511A (es) Tratamiento o prevención de eventos cardiovasculares.
ECSP088869A (es) Derivados de 2-pirazinona para el tratamiento de enfermedades o condiciones en donde resulta beneficiosa la inhibición de la actividad de la elastasa neutrofílica
DE602005016929D1 (de) Liganden für den cannabinoidrezeptoren
ATE536349T1 (de) In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
CY1108230T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
EA200600223A1 (ru) Замещённый 2-аминотетралины для лечения депрессии
ATE356621T1 (de) (s)-2-n-propylamino-5-hydroxytetralin als d3- agonistisches therapeutikum
SE0301232D0 (sv) Novel use
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
EA200700909A1 (ru) Азаиндолкарбоксамиды
DE602007002915D1 (de) 2-benzoyl-imidazopyridin-derivate, herstellungsverfahren und ihre verwendung für therapeutika
SE0401465D0 (sv) New substituted piperdines as modulators of dopamine neurotransmission
TW200611693A (en) GPR35 and modulators thereof for the treatment of metabolic-related disorders
DE602006004735D1 (de) Thiazolopyrimidine zur verwendung in der therapie
SE0301883D0 (sv) New use II
DE602005024192D1 (de) Chinazolinderivate als Phosphodiesterasehemmer zur Verwendung für die Behandlung peripherer Arterienerkrankungen
SE0301885D0 (sv) New use IV
SE0301884D0 (sv) New use III
SE0402591D0 (sv) Novel use
EA200701813A1 (ru) Новые амидозамещенные 6-фенилфенантридины
DE602005017629D1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1896031

Country of ref document: EP